KELOWNA, BC – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company”), a worldwide chief in the end-to-end growth and manufacturing of revolutionary, cannabinoid-based merchandise, right now introduced its participation in a Medical Cannabis Real-World Evidence Study (the “MC-RWE Study”) led by Dr. Hance Clarke of the University Health Network (UHN) in Toronto, Canada. The examine will discover the therapeutic results of medical hashish in adults with persistent ache, sleep, or anxiousness points, and can leverage the blockchain safe know-how of the Medical Cannabis by Shoppersonline product portal of each examined and verified hashish merchandise.
The Valens Company has contributed to the examine with the inclusion of Nūance, its unique model of premium hashish oil developed by the Company for Medical Cannabis by Shoppers. As a part of the examine, the Nūance line of THC and CBD oils shall be examined, with the verified outcomes on every batch made accessible by means of the Medical Cannabis by Shoppers portal for every doctor and affected person. Patients will have the ability to establish the contents of their product by means of the platform, together with efficiency ranges of THC and CBD, and confidently depend on the info to make sure batch-to-batch consistency and high quality. The objective of this examine is to supply physicians, pharmacists, and sufferers with confidence in medicinal hashish merchandise as an alternate therapy for numerous illnesses, together with ache reduction.
“Nūance oils are developed exclusively for Shoppers Drug Mart with medical cannabis patients at the core. To be able to participate in this real-world study and have the opportunity to understand how our products could be used as a treatment is an exciting step in the right direction for us,” mentioned Tyler Robson, Chief Executive Officer of The Valens Company. “With insights and data from this study, we look forward to further advancing our commitment to developing and testing the highest-quality and most reliable products for patients using cannabis for both medical purposes as well as recreational consumers.”
“Medical Cannabis by Shoppers is best placed to offer Canadians the reassurance of medical products that have been tested and validated,” mentioned Ken Weisbrod, Vice President, Business Development/Cannabis Strategy, Shoppers Drug Mart. “Our development of a blockchain secured initiative with TruTrace has now been integrated into an operational portal that will provide products with an immutable digital identity that can capture everything from detailed chemistry down to its DNA.”
The MC-RWE Study is a potential, non-interventional, observational examine to explain the advantages of medical hashish for numerous frequent medical points and seeks to enroll no less than 2,000 topics from throughout Canada who shall be adopted for 24 weeks. More on this examine may be discovered right here: https://www.uhn.ca/corporate/News/Pages/UHN_putting_medical_cannabis_to_the_test_in_first_real-world_evidence_clinical_trial.aspx.
About The Valens Company
The Valens Company is a worldwide chief in the end-to-end growth and manufacturing of revolutionary, cannabinoid-based merchandise. The Valens Company is targeted on being the associate of alternative for main Canadian and worldwide hashish manufacturers by offering best-in-class, proprietary providers together with CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation and product growth and customized manufacturing. Valens is the most important third-party extraction firm in Canada with an annual capability of 425,000 kg of dried hashish and hemp biomass at our purpose-built facility in Kelowna, British Columbia which is in the method of changing into European Union (EU) Good Manufacturing Practices (GMP) compliant. The Valens Company at present gives a variety of product codecs, together with tinctures, two-piece caps, tender gels, oral sprays and vape pens in addition to drinks, concentrates, topicals, edibles, injectables, pure well being merchandise and has a powerful pipeline of next-generation merchandise in growth for future launch. Finally, The Valens Company’s wholly-owned subsidiary Valens Labs is a Health Canada licensed ISO 17025 accredited hashish testing lab offering sector-leading analytical providers and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant-Based Science. For extra data, please go to http://thevalenscompany.com